FINWIRES · TerminalLIVE
FINWIRES

Ashoka Buildcon's Consolidated Profit Falls in Fiscal Q4; Shares Fall 4%

By

Ashoka Buildcon (NSE:ASHOKA, BOM:533271) said its consolidated profit attributable to the owners fell to 1.43 billion Indian rupees in the fiscal fourth quarter from 4.32 billion rupees a year ago, according to a Thursday filing on Indian bourses.

The company's shares fell over 4% in Friday's trade.

Earnings per share for the quarter ended March 31 contracted to 5.51 rupees from 15.40 rupees a year earlier.

Revenue from operations of the construction company increased also declined to 19.5 billion rupees from 26.9 billion rupees, the filing said.

Related Articles

Asia

Nomura Adjusts Samvardhana Motherson International's Price Target to INR155 From INR140, Keeps at Buy

Samvardhana Motherson International (NSE:MOTHERSON, BOM:517334) has an average rating of overweight and mean price target of 149.05 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BOM:517334$NSE:MOTHERSON
Asia

Nomura Adjusts JSW Steel's Price Target to INR1,400 From INR1,340, Keeps at Buy

JSW Steel (NSE:JSWSTEEL, BOM:500228) has an average rating of overweight and mean price target of 1,361.28 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BOM:500228$NSE:JSWSTEEL
Asia

Nomura Adjusts Anthem BioSciences' Price Target to INR900 from INR740, Keeps at Buy

Anthem BioSciences (NSE:ANTHEM, BOM:544449) has an average rating of buy and mean price target of 879.43 Indian rupees, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$BOM:544449$NSE:ANTHEM